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INTRODUCTION
Bacteroides is the predominant member of hu-
man colonic microbiota. The environment of the
lower intestine is poor in mono- and di-saccha-
rides, most of which are absorbed by the host and
the microbiota in the upper intestinal tract. Analy-
sis of the three Bacteroides genomes B. fragilis (1),
B. thetaiotaomicron (2) and B. vulgatus (3) revealed
that Bacteroides is able to utilize a broad range of
dietary and host-derived polysaccharides (4-8).
These anaerobes have an exceptionally large num-
ber of genes involved in the utilization of a variety of
complex polysaccharides (e.g., glycosylhydrolases,
glycosyltransferases, and outer membrane polysac-
charide-binding proteins). Although human colo-
nic bacteria are commonly enriched for genes in-
volved in polysaccharide utilization, the number of
glycosylhydrolase genes in Bacteroides species is
much higher than in other sequenced colonic bac-
teria such as Bifidobacterium longum, Clostridium
perfringens and Enterococcus faecalis (9, 10). In
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addition, many of the glycosylhydrolase genes colo-
calize with genes for the SusC/SusD family of pro-
teins (outer membrane proteins involved in poly-
saccharide recognition and transport), extracellular
function-type sigma factors and their cognate anti-
sigma factors (3, 5, 11, 12), allowing Bacteroides to
sense and utilize various types of polysaccharides.
These adaptations in Bacteroides reflect the poly-
saccharide-rich environment in the human colon.
Sialidase (neuraminidase, EC 3.2.1.18) is an en-
zyme responsible for the cleavage of N -acetylneu-
raminic acid (sialic acid) from glycoproteins and
glycolipids on host cell surfaces or in body fluids.
It plays a key role in the sequential degradation of
host-derived sialoglycoconjugates, and has been
linked to the virulence of various pathogens (13,
14). Similarly, the most pathogenic Bacteroides spe-
cies, B. fragilis , has a much higher level of siali-
dase activity than other Bacteroides spp . (15), an
activity that is involved in the growth and survival
of B. fragilis on tissue culture monolayers and in rat
granuloma pouches in vivo (16). Four sialidase
genes (designated nanH1 to nanH4) have been iden-
tified in the genome of B. fragilis strain YCH46,
while only two are found in B. thetaiotaomicron strain
VPI-5482. These findings indicate that the host-de-
rived polysaccharides are major nutritional sources
for B. fragilis as well as dietary polysaccharides. As
shown in Fig. 1, a number of genes for polysaccha-
ride utilization such as glycosylhydrolases, outer
membrane receptor proteins (SusC/SusD family),
and transporters are clustered with sialidase genes
in the B. fragilis YCH46 genome. Of these, the 27-
kb region that includes nanH1 is unique in that it
contains (i) a much higher number of glycosylhy-
drolase genes than other loci and (ii) a sialate O -
acetylesterase homologue, a rate-limiting enzyme
of sialic acid catabolism that catalyzes removal of
acetyl groups from O -acetylated sialic acid in sialo-
glycoconjugates (17, 18). Streptococcus pneumoniae
sialidase and exoglycosidases sequentially deglyco-
sylate human glycoconjugates, such as IgA1, to fa-
cilitate growth and colonize airways (19). In addi-
tion, this sequential deglycosylation of human serum
increases resistance to complement deposition and
subsequent phagocytic killing of S. pneumoniae (20).
Thus, sialidase and other glycosylhydrolases may
contribute to the ability of B. fragilis to establish a
Fig. 1. Genomic region around the four sialidase paralogues (nanH1 to nanH4 , shown by closed boxes) in B. fragilis YCH46. Pre-
dicted coding regions are represented by open boxes with internal arrows showing transcriptional direction. Gene identifications are
shown under the boxes. Putative functions of ORFs are listed in the table. Functions of the genes in locus-1 are summarized in
Table 3.
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stable colonization of the gut.
In this study, we characterized the sgu (sialo-
glycoconjugates utilization) locus, the 27-kb gene
cluster that contains nanH1 , and demonstrated its
importance in the process of B. fragilis colonization
of the host intestinal tract.
MATERIALS AND METHODS
Bacterial strains, plasmids and culture conditions
The bacterial strains and plasmids used in this
study are listed in Table 1. All of the Bacteroides
strains were grown anaerobically at 37in Gifu
Table 1. Bacterial strains and plasmids
Strain or plasmid Relevant genotype or description Reference or source
Strains
Escherichia coli
XLI-Blue end Δ1 hsdR17 (rK-mK+) supE44 thi-1λ- recA1 gyrA96 (NalR) relA1 (Δlac) [F‘ proAB +
lacI qZΔM15 : : Tn10 (TcR)]
Stratagene
GMS407 lacY1 galK2(Oc) λ- manA4 , uidA1 , mtl-1 , argE3(Oc) E. coli Genetic Stock Centre
Bacteroides fragilis
ATCC25285 Type strain, appendix abscess ATCC
ATCC43859 Laboratory strain, enterotoxigenic, bft2 36, ATCC
GAI97124 Clinical isolate, enterotoxigenic, bft2 37
YCH46 Clinical isolate 1
YCH2 Clinical isolate I. Nakamura, Perianal abscess
YCH4 Clinical isolate I. Nakamura, Abscess at vulva
YCH9 Clinical isolate I. Nakamura, Peritoneal abscess
YCH21 Clinical isolate I. Nakamura, Blood
YCH44 Clinical isolate I. Nakamura, Abscess at ab-
dominal wall
TDP101 Clinical isolate 38
B1 Clinical isolate Peritoneal abscess
KMS5 Clinical isolate Abscess
SGUM172941 YCH46 mutant with deletion of BF1729-BF1741 This study
B. uniformis
BU1001 Laboratory strain, GnR 39
Plasmids
pUC19 E. coli cloning vector ; ApR Nippon gene
pBluescript II KS E. coli cloning vector ; ApR Stratagene
pGEM-T easy E. coli cloning T-vector ; ApR Promega
pT7blue E. coli cloning T-vector ; ApR Novagen
pVAL-1 E. coli -Bacteroides shutle vector ; ApR TcR in E. coli , EmR in Bacteroides ; Mob+ Rep+ 40
R751 Mobilizable plasmid used to move plasmids from E. coli to B. uniformis ; Tra+ TpR 39
pNAND100 5.2 -kb PCR fragment generated with primers APF1 and APR2 cloned into pT7blue,
estS +, bmnA+
This study
pNAND170 3.2 -kb bmnA fragment derived from pNAND100 cloned into pBluescript II KS, bmnA+ This study
pNAND200 3.4 -kb PCR fragment generated with primers KPF1 and H2R-3 cloned into pT7blue,
estA+, estS +
This study
pNAND240 3.4 -kb estA/S fragment derived from pNAND200 cloned into pBluescript II KS, estA+,
estS +
This study
pNAND241 3.1 -kb estS fragment derived from pNAND240 in pBluescript II KS, estS + This study
pNAND244 0.9 -kb estA fragment derived from pNAND240 in pBluescript II KS, estA+ This study
pVNAND241 3.1 -kb estS fragment derived from pNAND241 cloned into pVAL-1, estS + This study
pNAND300 3.0 -kb bgaA -PCR fragment generated with primers EIFZ4/new and ClaR8, cloned
into pGEM-T easy , bgaA+
This study
pNAND400 3.4 -kb bgaB -PCR fragment generated with primers LONGsusD-F and LONGdnaJ -R
cloned into pGEM-T easy, bgaB +
This study
pOT3014 5.6 -kb nanH1 -nahA -estA fragment cloned into pHSG399, nanH1+, nahA+, estA+ 22
pNAKS 2.5 -kb nahA fragment derived from pOT3014 cloned into pBluescript II KS, nahA+ This study
pGN-1 6.2 -kb nahB -nanM -nahC -PCR fragment generated with primers 3F-1 and KIW-R
cloned into pGEM-T easy, nahB +, nanM +, nahC +
This study
pNAP-1 2.8 -kb nahB fragment derived from pGN-1 cloned into pUC19, nahB + This study
pNAP-3 3.4 -kb nahC fragment derived from pGN-1 cloned into pUC19, nahC + This study
Abbreviations : Ap, ampicillin ; Em, erythromycin ; Gn, geneticin ; Nal, nalidixic acid ; Sm, streptomycin ; Tc, tetracycline ; Tp,
trimethoprim ; Mob, ability to be mobilized by self - transmissible plasmid ; Rep, ability to replicate in Bacteroides ; Tra, ability to self -
transfer.
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anaerobic medium (GAM) broth (Nissui Pharmaceu-
tical Co., Tokyo, Japan) or on GAM agar plates using
the AnaeroPack System (Mitsubishi Gas Chemical
Co., Inc., Tokyo, Japan) or an anaerobic chamber
conditioned with mixed gases (N2, 80% ; CO2, 10% ;
and H2, 10%). Escherichia coli strains were routinely
grown aerobically at 37 in Luria-Bertani (LB)
broth or on LB agar plates. If necessary, antibiotics
were added to the media at the following final con-
centrations : ampicillin (Ap), 50 μg/ml ; erythromy-
cin (Em), 10 μg/ml ; and gentamycin, 400 μg/ml.
In silico analysis of the sgu locus
The 27-kb sgu locus was identified in the com-
plete genome sequence of B. fragilis strain YCH46
(Locus 1 in Fig. 1). Open reading frame (ORF) pre-
dictions and protein functional annotation were car-
ried out as previously described (1). The similarity
of deduced protein sequences to those in public
databases was examined using BLASTP from the
National Centre for Biotechnology Information
(http : //www.ncbi.nlm.nih.gov/BLAST/). Align-
ments of nucleotide or amino acid sequences were
performed using Clustal W (http : //clustalw.
genome.ad.jp/). DNA sequencing was performed
using an ABI PRISM BigDye Terminator Cycle Se-
quencing Ready Reaction Kit, version 1.1 (Applied
Biosystems, Foster City, CA) followed by analysis
of the products on an ABI PRISM 3100 Genetic
Analyzer (Applied Biosystems).
DNA manipulations
Standard molecular biology procedures were per-
formed as described by Sambrook et al. (21). Re-
striction enzymes, DNA ligase, and DNA polym-
erase were used in accordance with the manufac-
turer’s instructions. Synthetic oligonucleotide prim-
ers were purchased from Sigma-Aldrich Japan Co.,
Ltd. (Tokyo, Japan).
Construction of plasmids
As shown in Fig. 2A, regions within the sgu locus
were separately amplified to subclone the putative
glycosylhydrolase genes into E. coli cloning vectors.
Amplification products of 5.2, 3.4, and 6.2 kb gener-
ated by primer sets APF1 and APR2, KPF1 and H2R-
3, and 3F-1 and KIW-R were cloned into a pT7blue
vector to construct pNAND100, pNAND200, and
Fig. 2. Genetic organization of the 27-kb region (sgu locus) containing nanH1 in B. fragilis YCH46 (A). Predicted coding regions
are represented by open boxes with internal arrows showing transcriptional direction. Putative regulatory regions are indicated by
bent arrows (promoter) and hairpin structures (transcriptional terminators). (B) Plasmids used in this study. Lines denote the DNA
regions subcloned into individual plasmids. (C) ΔBF1729-1741 indicates the region that was deleted in the chromosome of mutant
SGUM172941. (D) Diagrammatic representation of the PCRs performed to compare the genetic organization of sgu locus among B.
fragilis strains.
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pGN-1, respectively. The 3.2-kb Hinc II/Cla I-di-
gested fragment containing bmnA from pNAND100
was subcloned into a pBluescript II KS vector to
construct pNAND170. The 3.4-kb fragment contain-
ing the estA/S genes, from the Xba I/Sma I-diges-
tion of pNAND200, was subcloned into a pBluescript
II KS vector to construct pNAND240. The 0.9-kb
estA and 3.1-kb estS fragments produced by Pst I-
and Sty I/Xba I-digestion of pNAND240 were reli-
gated to construct pNAND244 and pNAND241, re-
spectively. The 2.8-kb nahB and 3.4-kb nahC frag-
ments obtained by Sph I/Xho I- and BamH I/EcoR
I-digestion of pGN-1 were subcloned into pUC19
to construct pNAP-1 and pNAP-3, respectively. The
plasmid pNAKS was constructed by subcloning the
2.5-kb Pvu II/Pst I-digested fragment containing
nahA from pOT3014 (22) into a pBluescript II KS
vector. The 3.0-kb and 3.4-kb fragments contain-
ing bgaA and bgaB were amplified using the primer
set EIFZ4/new and ClaR8 and the primer set
LONGsusD-F and LONGdnaJ-R and cloned into a
pGEM-T easy vector to construct pNAND300 and
pNAND400, respectively. For the sialate O-acetyles-
terase assay in B. uniformis strain BU1001, mobi-
lization of the E. coli-Bacteroides shuttle plasmid
pVNAND241 carrying the estS gene from E. coli
to B. uniformis was performed with a filter mating
procedure using mobilizer plasmid R751 as previ-
ously described (22). The nucleotide sequences and
annealing positions of oligonucleotide primers used
for plasmid constructions are shown in Table 2.
Construction of deletion mutants
Deletion of the sgu locus (BF1729-BF1741) in
Table 2. Oligonucleotide primers
Primer name Sequence (5’ to 3’) Primer name Sequence (5’ to 3’)
APF1 TAAGGGACATCGTCCTTACATGCAGCAAGA KIW-F13 TAACTATCGATATGGGTGAG
APR1 TCTTATAATGATCGGTTACCGGAAGTACAC KIW-R AACGTTCAATTTTCCGGTTGT
APR2 GGCTTCTTCCTGAGTATAGAAACCACCGTA KIW-R4 ATGGATCAGGTAACTCTGTA
ClaR1 CGAGTGACTGATTGCAAAGACTGACCACCT KIW-R6 TCAGATTGGTATACAACAGG
ClaR6 TCCGGATTTCGGTGATTGGG KIW-R8 TGTCTCATTCTCTTTACGCT
ClaR8 AGGGCAAAAGTCAATGTCGG KIW-R9 TCGATACTGAGACTCCATAA
ClaR10 AATCGAATCCGGTCCATACG KKF-1 TACATTCCGTCATGATAT
ClaR16 CTTTCATCCAGGTATCCACG KKF-2 TTACGTAGCTAACGAACGCAAT
EIFZ TGGCTATTGGAAGAAGATGCGTCCGATGAC KKR-1 ATTGCGTTCGTTAGCTA
EIFZ4/new TGCCGAATATTTCACTGACCG KPF1 ATGCAGTGGACGGACTTATCTA
EIFZ7 AAGCTTGTGATGAAATGGGC LONGdnaJ -R TGCCAAGCGTAAACGGCTATGGTACAGGAG
EIFZ9 GTTATCGCCTGATGTGGATG LONGsusD-F CACTTATACGGGCAGACCTCAACTTTCGGG
EIFZ11 TTGGTGACCTCAGTATGCTC nahB-F GATTGACTTGCAACAACCTACCGAGATCTCC
EIFZ16 ATCTGGCTACTATCACAGGC nanH-P11 CCTTTCAGAACAACCTGATTACCGGG
estA-1F CGTGCAACTCTGTTTGAGGA NF1 AGTACAGATGGTGGAAAAAC
H2F-3 TGCGCAACCATGCTTCATTG NhAR1 CCAGTTTCACTTCAATACTTGCACGAGC
H2R-1 AATCGCGGTAAATCCGTGTC NR5 TCTTTTGTAATAGCCACAGC
H2R-3 GATACCGCTTGTAACCATGC PBF ATTGAGTATACTAATGATGG
H3F-2 CAGTTGTCAAGTATCAACCG SALF GTCGACTACCGGATGTATTA
H3R-2 CTGCTGTTGCAGGTGAACAA SauR1 GAACGGTCACAGATTGCCAC
HaeF2 CGATTGATGAAACTGCCACC SUSInvF1 GTGGATAATGATGCCATTCAAGCCACGTGG
HaeF4 ATTGGCTTTAGAGGCCGATG Δgal -R ACTTCCCGACAGGTCTATCTTTGTGACCTGC
HaeR2 TGGTCTACCATCACCAATCG 3F-1 GTCCAGATTCCTGTTCAAGG
HaeR3 CTCTTATCGGATATATCGGG 3F-2 CGTAAGTCTATTCCGGTAGC
HaeR6 TACAGAGTCTTGCTCATCGG 3R-1 GTTGGCTTTGAGCAGTCGTA
InvRF TCAACTAAGATTGGGGAAGTGGCTGAAGAA nanH-1 GCTCTAGACCAGTGATGGTAACTGGAGTTTCAGC
IPMR1 CCAATACGGTTCACAATTGTATCTGC nan-1 CCGGATACCATGTGCTGCTTGAACTACCGGTATAG
KIW-F5 TTTGGGTGTATCGGCATGTTAT nan-2 AAGCAGCAGATGGTATCCGGCATTGATTTCTGGCA
KIW-F8 TTTCTACTGACGGATACTGTT nanH-8 GCTCTAGAACCGTTAGCACCGATGATACCATAAC
KIW-F11 TATTCCTGAGATCGAAATGC estAS-3 AATCCTCTTCACGTGCGTTACGGTT
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B. fragilis YCH46 was accomplished by removing
the 26.8-kb internal segment of the cluster (Fig.
2C). Briefly, DNA fragments upstream and down-
stream of the target region were separately PCR-
amplified using primer sets nanH-1 and nan-1 (up-
stream fragment), and nan-2 and nanH-8 (down-
stream fragment). These amplicons were fused by
a second PCR amplification using the primer set
nanH-1 and nanH-8 via overlapping regions incorpo-
rated into the primer sequences. The resultant PCR
products were ligated into pKK100 (23). The tar-
geting plasmids were electroporated into B. fragilis
YCH46 as described previously (23, 24). Diploids,
in which the targeting plasmid integrated into the
chromosome via a single genetic crossover, were
selected on GAM agar plates containing Em. The
diploids were grown in GAM broth, spread on
nonselective GAM agar plates, and replica plated
onto GAM agar plates containing Em to screen for
mutants that resolved the diploid through a sec-
ond homologous recombination. Em-sensitive colo-
nies were selected, and the expected deletion was
checked by PCR with primer pairs estAS-3 and
LONGdnaJ-R, which flanked the deletion site (Table
2).
PCR scanning of the sgu locus among B. fragilis
strains
As shown in Fig. 2D, six segments of the sgu lo-
cus were separately amplified to compare the genetic
organization in 12 B. fragilis strains (PCRs A to F).
Segments were amplified using primer sets InvRF
and H3R-2 (PCR A), APF1 and APR2 (PCR B), 3F-
2 and ClaR16 (PCR C), EIFZ and ClaR1 (PCR D),
EIFZ16 and HaeR2 (PCR E), or LONGsusD-F and
LONGdnaJ-R (PCR F). PCR amplification was per-
formed with an iCycler Thermal Cycler (Bio-Rad)
using TaKaRa EX Taq DNA polymerase (Takara
Shuzo Co., Ltd., Otsu, Japan) using the following
parameters : preheating at 94for 1 min, 30 cycles
of 94 for 30 s and 68 for 10 min, and a final
extension at 68for 10 min. The nucleotide se-
quence and annealing position of each primer are
shown in Table 2.
Enzyme assays
Recombinant clones of E. coli or B. uniformis
grown, in LB broth containing 50 μg/ml of Ap or
in GAM broth containing 10 μg/ml of Em, were
harvested, washed once with 50 mM sodium phos-
phate buffer (pH7.4), and resuspended in four vol-
umes of buffer. The cells were disrupted by 50%
pulsed sonication in an ice bath for 5 min and then
centrifuged at 9,000g for 30 min at 4. The su-
pernatants were used for measurement of enzyme
activities. Mucin purified from bovine submaxillary
glands (Type I-S, Sigma), p -nitrophenyl acetate
(pNPA), pNP-glycosides of β -D-galactopyranoside
(pNPβGal), α -D-mannopyranoside (pNPαMan), β -
D-mannopyranoside (pNPβMan), N -acetyl-β -D-
glucosaminide (pNPβGlcNAc), and β -D - glucuron-
ide (pNPβGlcU) were used as substrates in the
enzyme assays. Enzymatic hydrolysis of the pNP-
glycosides was carried out at 37in 500 μl of 50
mM sodium phosphate buffer (pH7.4) for up to 3 h
at a substrate concentration of 1 mM before absor-
bance was measured at 400 nm. Sialate O-acetyles-
terase activity was assayed with mucin as described
previously (17).
Reverse transcription (RT)-PCR analysis
B. fragilis YCH46 was grown in GAM broth,
washed once with phosphate -buffered saline
(pH7.4), and transferred to pre-reduced PY (polypep-
tone-yeast extract) liquid medium (25) containing
one of the following mono- or oligo-saccharides as
a carbon source : glucose, 0.5% ; sialic acid, 0.5% ;
starch, 0.5% ; colominic acid, 0.5% ; mucin (type I-
S), 0.5% ; fetuin, 0.5% ; asialofetuin, 0.5% ; or chitin,
0.5%. All carbohydrates were purchased from Sigma.
Cell growth was monitored by measuring turbidity
with a photoelectric colorimeter (Fuji Kogyo Co.,
Ltd., Tokyo, Japan) at 660 nm. The cells were har-
vested at mid-logarithmic phase, and total RNA
was purified using an RNeasy Kit (QIAGEN) with
the additional step of treatment with RNAprotect
Bacteria Reagent (QIAGEN) and RQ1 RNase-Free
DNase (Promega) according to the manufactur-
ers’ instructions. RT-PCR was performed using a
OneStep RT-PCR Kit (QIAGEN) according to the
supplier’s instructions. Twenty-five nanograms of
total RNA was used for cDNA synthesis at 50for
30 min. The RT reaction was terminated by heat-
ing the mixture at 95for 15 min and the cDNA
products were amplified under the following con-
ditions : 30 cycles of 30 s at 94, 30 s at 55and
1 min at 72with a final extension step of 10 min
of 72. PCRs using the oligonucleotide primer sets
NF1 and NR5, KKF-1 and KKR-1, estA-1F and
IPMR1, APF1 and H3R-2, H2F-3 and H2R-1, 3F-2
and APR2, KIW-F5 and KIW-R8, KIW-F11 and
KIW-R4, EIFZ and ClaR16, EIFZ7 and ClaR10,
EIFZ11 and ClaR6, SUSInvF1 and HaeR6, and
HaeF4 and HaeR2 were performed to detect nanH1 ,
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nahA , estA , estS , bmnA , nahB , nanM , nahC , amnA ,
bgaA , BF1739, BF1740, and bgaB transcripts, re-
spectively. In addition, PCRs using the primer sets
SALF and nanH-P11, NF1 and NhAR1, KKF-2 and
APR1, PBF and H3R-2, H3F-2 and H2R-3, H2F-3
and 3R-1, nahB-F and KIW-R9, KIW-F8 and KIW-
R6, KIW-F13 and KIW-R, EIFZ4/new and SauR1,
EIFZ9 and ClaR8, EIFZ16 and ClaR, HaeF2 and
Δgal-R, LONGsusD-F and HaeR3, and LONGsusD-
F and HaeR2 were performed to detect the tran-
scripts that overlap BF1727-nanH1 , nanH1 -nahA ,
nahA -estA , estA -estS , estS -bmnA , bmnA -nahB , nahB -
nanM, nanM -nahC , nahC -amnA , amnA -bgaA , bgaA -
BF1739, BF1739-BF1740, and BF1740-bgaB , re-
spectively. 16S rRNA was used as an internal control
to compare the quantities of RNA in each reaction.
The RT-PCR products were separated by electro-
phoresis in 0.7% agarose gels. The nucleotide se-
quences and annealing positions of the oligonucleo-
tide primers are listed in Table 2.
In vitro growth comparisons
To compare the in vitro growth of the sgu-dele-
tion mutant (SGUM172941) to that of wild type,
each strain was grown separately in liquid media
containing one of a variety of carbohydrates as the
sole carbon source. Briefly, SGUM172941 and wild
type strains were grown in GAM broth, washed
once with phosphate-buffered saline (pH7.4), and
transferred to pre-reduced PY liquid medium (25)
containing 0.5% glucose or 0.5% mucin (type I-S)
as a carbon source. Growth was monitored by opti-
cal density at 600 nm using a spectrophotometer
(CO8000 Cell Density Meter, WPA, Cambridge,
UK).
Competitive colonization assay in the gut of germ-
free mice
Five-week-old male IQI/Jic germ-free mice (Clea
Japan Inc., Tokyo, Japan) were individually housed
in plastic cages under sterile conditions in a vinyl
isolator (Natsume Seisakusho Co., Ltd., Tokyo, Ja-
pan). Three mice each were used per experimental
group. Mice were fed standard laboratory chow ster-
ilized by gamma irradiation (50 kGy) and received
autoclaved tap water ad libitum. The gut coloniza-
tion capacity of SGUM172941 was assessed by in-
oculating germ-free mice with a 0.4-ml cocktail con-
taining 2.0108 viable cells each of the wild type
and the mutant strains. Ileal mucosa, ileal contents,
caecal contents, colonic mucosa, and colonic con-
tents were collected for one week after inoculation to
compare the population levels of the wild type and
SGUM172941 strains. Serial sample dilutions were
spread on GAM agar plates, and 96 colonies were
screened per sample. Wild type and SGUM172941
strains were distinguished by colony-PCR with prim-
ers flanking the sgu locus-deletion site. All animal
experiments were performed according to the guide-
lines approved by the Animal Committee of the
University of Tokushima.
Nucleotide sequence accession number
The nucleotide sequence of the sgu locus of B.
fragilis YCH46 described in this study has been as-
signed DDBJ/EMBL/GenBank accession number
AP006841.
RESULTS
General features of the region containing nanH1 in
B. fragilis strain YCH46
In silico analysis of the complete genome se-
quence of B. fragilis YCH46 revealed a large cluster
of genes encoding proteins involved in sialoglyco-
conjugate utilization. The first gene of the cluster
was identified as a sialidase gene (nanH1) (Fig. 2).
This gene cluster contained 13 unidirectionally tran-
scribed open reading frames (ORFs), ten of them
(BF1729-BF1734, BF1736, BF1737, BF1738 and
BF1741) encoding putative glycosylhydrolases.
Within the 27-kb chromosomal segment, BF1729 to
BF1735, BF1736 to BF1738, and BF1739 to BF1740
were tightly organized without any obvious tran-
scriptional initiation signals and transcriptional ter-
minators within the intervening regions. Bacteroides
promoter consensus sequences (TAnnTTTG) cen-
tered at -7 from the transcriptional initiation site
(26) were found upstream of nanH1 (BF1729),
BF1736, and BF1741. Inverted repeat sequences
that form stem-loop structures, which possibly work
as a transcriptional terminator, were found upstream
of nanH1 and downstream of BF1738, BF1740, and
BF1741. Analysis of the base composition of this
cluster revealed an overall G+C content (43.43%)
similar to that of the B. fragilis YCH46 chromosome.
Putative functions of ORFs were assigned based on
homology to proteins in databases and are summa-
rized in Table 3.
This 27-kb region, which contains genes that ap-
pear to be involved in the binding, degradation and
transport of sialated polysaccharides, was designated
as the sgu (sialoglycoconjugate utilization) locus.
The Journal of Medical Investigation Vol. 59 February 2012 85
Comparison of the sgu gene cluster in Bacteroides
The sgu locus was divided into six overlapping
segments (A to F). These segments were separately
amplified in 12 strains of B. fragilis (two laboratory
strains and ten clinical isolates) using PCR primer
sets that were synthesized on the basis of the nu-
cleotide sequence of the sgu locus (Panel D in Fig.
2). As summarized in Table 4, all of the strains
tested produced a PCR product from segments
A to D, indicating that the region from nanH1 to
BF1740 in the sgu locus is highly conserved among
Table 3. Similarity of putative ORFs in the sgu locus to public database sequences
ORF Size(no. of aaa)
Best homology to functionally
known protein
(organism/% aa identity/accession no.)
Conserved domain structureb Putative function of protein
BF1730 (nahA) 670 β -N -acetylhexosaminidase
(Porphyromonas gingivalis/27%/P49008)
Catalytic domain (pfam00728) and
domain 2 (pfam02838) for glyco-
sylhydrolase family 20
β -N -acetylhexosaminidase
BF1731 (estA) 220 α2 subunit of platelet -activating facter ace-
tylhydrolase Ib (rat/27%/O35264)
Conserved residues Ser -Gly -Asn-
His of SGNH - hydrolase family,
sialate O -acetylesterase (cd01828)
Sialate O -acetylesterase
BF1732 (estS ) 690 Sialate O -acetylesterase
N-terminal domain 220 Arylesterase (Vibrio mimicus/25%/Q07792) Conserved residues Ser -Gly -Asn-
His of SGNH - hydrolase family,
sialate O -acetylesterase (cd01828)
C-terminal domain 470 Sialic acid-specific 9 -O -acetylesterase
(mouse/28%/P70665)
-
BF1733 (bmnA) 856 β -mannosidase BT0458
(Bacteroides thetaiotaomicron/76%/NP_
809371)
TIM barrel domain of glycosylhy-
drolase family 2 (pfam02836)
β -mannosidase
BF1734 (nahB ) 747 N -acetyl -β -glucosaminidase
(Tannerella forsythensis/39%/AAO33832)
Catalytic domain (pfam00728) and
domain 2 (pfam02838) for glycosyl-
hydrolase family 20. F5/8 type C do-
main (pfam00754).
β -N -acetylhexosaminidase
BF1735 (nanM ) 404 N -acetylneuraminic acid mutarotase
(Escherichia coli/24%/2UVK_A)
Kelch motifs (pfam01344), cycli-
cally-permuted mutarotase family
(TIGR03548)
N -acetylneuraminic acid mu-
tarotase, the conversion of
the α - sialic acid isomer to
the β form.
BF1736 (nahC ) 689 N -acetyl -β -glucosaminidase
(Tannerella forsythensis/45%/ AAO33832)
Catalytic domain (pfam00728) and
domain 2 (pfam02838) for glycosyl-
hydrolase family 20
β -N -acetylhexosaminidase
BF1737 (amnA) 749 Immunoreactive 87 kD antigen PG92
(Porphyromonas gingivalis/59%/AAD51077)
α -1,2 -mannosidase (Bacillus sp./26%/
BAA76709)
Glycosyl hydrolase family 92 (pfam
07971), α -1,2 -mannosidase (TIGR
01180)
α -mannosidase
BF1738 (bgaA) 833 β -galactosidase
(Xanthomonas campestris pv. campestris/
40%/AAP86765)
Sugar -binding domain (pfam02837),
TIM barrel domain (pfam02836),
and immunoglobulin β - sandwich
domain (pfam00703) of glycosylhy-
drolase family 2
β -galactosidase
BF1739 914 Outer membrane protein involved in starch
binding, SusC
(Bacteroides thetaiotaomicron/28%/NP_
812613)
TonB-dependent receptor domain
(pfam00593)
SusC homolog, polysaccha-
ride binding outer mem-
brane protein
BF1740 543 Outer membrane protein, SusD
(Bacteroides thetaiotaomicron/26%/NP_
812612)
SusD family (pfam07980) SusD homolog, polysaccha-
ride binding outer mem-
brane protein
BF1741 (bgaB ) 928 β -galactosidase
(Pseudoalteromonas haloplanktis/24%/
CAA10470)
Sugar -binding domain (pfam02837),
TIM barrel domain (pfam02836),
and immunoglobulin β - sandwich
domain (pfam00703) of glycosylhy-
drolase family 2
β -galactosidase
a aa, amino acids.
b Conserved domains based on the Conserved Domain Database (http : //www.ncbi.nlm.nih.gov/Structure/cdd/cdd.shtml).
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B. fragilis strains. However, bgaB (β -galactosidase
gene) was absent in six strains. Segment E-posi-
tive strains produced the expected 3.4-kb product,
while segment E-negative strains generated a 0.5-
kb PCR product (PCR F). Comparison of the nu-
cleotide sequences of these 3.4-kb and 0.5-kb prod-
ucts revealed that bgaB is deleted via a 13-bp direct
repeat sequence in segment E-negative strains (data
not shown). To date, four B. fragilis strains have
been sequenced. The structure of the sgu locus was
highly conserved in these four strains, but the bgaB
gene was absent in strains NCTC9343 and 638R
(Fig. 3A).
To determine whether sgu - like regions are pre-
sent in other bacterial species, we searched for gene
clusters containing homologues of the sialidase,
sialate O -acetylesterase and glycosylhydrolase genes
in public databases. The sgu - like region was identi-
fied in many Bacteroides species : B. caccae, B. dorei ,
B. fluxus , B. intestinalis , B. helcogenes , B. ovatus, B.
thetaiotaomicron , and B. vulgatus. Comparative analy-
sis of the genetic organization of sgu loci among B.
fragilis , B. vulgatus, and B. thetaiotaomicron demon-
strated a high degree of synteny. However, BF1739,
BF1740, and bgaB were absent in B. vulgatus and
B. thetaiotaomicron . In addition, estA , nanM and
amnA were absent in B. thetaiotaomicron (Fig. 3B).
Table 4. Comparative PCR scanning of the sgu locus among
B. fragilis strains
Results of PCR a
Strains A B C D E F (kb)b
ATCC25285 + + + + 0.5
ATCC43859 + + + + + 3.4
YCH2 + + + + + 3.4
YCH4 + + + + 0.5
YCH9 + + + + 0.5
YCH21 + + + + + 3.4
YCH44 + + + + 0.5
YCH46 + + + + + 3.4
TDP101 + + + + + 3.4
B1 + + + + 0.5
KMS5 + + + + 0.5
GAI97124 + + + + + 3.4
a Plus indicates that the product of expected size was success-
fully amplified.
b Size of PCR product.
Fig. 3. Comparison of the sgu locus among B. fragilis strains (A) and Bacteroides species (B). BV : Bacteroides vulgatus ; BF :
Bacteroides fragilis ; and BT : Bacteroides thetaiotaomicron . Homologous ORFs are linked. Amino acid sequence identities between
homologous ORFs are indicated. The genetic structure of the region is conserved among B. fragilis strains and that the regions cor-
responding to regulatory units 1 and 3 are also conserved in B. vulgatus and B. thetaiotaomicron .
The Journal of Medical Investigation Vol. 59 February 2012 87
Functional analysis of the putative glycosylhydrolase
genes in the sgu locus
Putative glycosylhydrolase genes (nahA , estA ,
estS , bmnA , nahB , nahC , amnA , bgaA , and bgaB )
in the sgu locus were individually subcloned into a
plasmid and introduced into E. coli (Fig. 2B). Gly-
cosylhydrolase activities in crude extract of each re-
combinant E. coli strain were measured using vari-
ous synthetic substrates (Fig. 4).
β -N - acetylhexosaminidase activity against
pNPβGlcNAc was determined in crude extracts from
E. coli cells carrying nahA (pNAKS), nahB (pNAP-
1) or nahC (pNAP-3). β -N -acetylhexosaminidase
activity of E. coli harboring pNAP-1 was 7.5-fold
higher than that in E. coli cells with pNAP-3, while
no β -N -acetylhexosaminidase activity was detected
in E. coli harboring pNAKS.
Arylesterase and sialate O -acetylesterase activi-
ties were measured in E. coli strains carrying the
plasmid pNAND244 (estA) or pNAND241 (estS )
using pNPA and mucin, respectively. High levels
of arylesterase and sialate O -acetylesterase activi-
ties were found in E. coli transformants harboring
pNAND244, while no activity was detected in E. coli
cells carrying pNAND241. It is presumed that the
cloned estS gene was not expressed in E. coli due
to differences in the transcription/translation sys-
tems or in posttranslational processing between E.
coli and Bacteroides since both activities were de-
tected in B. uniformis carrying pVNAND241. The E.
coli strain harboring pNAND170 (bmnA) showed a
high level of β-mannosidase activity when pNPβMan
was used as a substrate.
The β -galactosidase activity of E. coli cells har-
boring the plasmid pNAND300 or pNAND400 was
Fig. 4. Glycosylhydrolase activities of recombinant E. coli or B. uniformis clones. Glycosylhydrolase activities against various syn-
thetic substrates were tested in each crude extract. (A) β -N -acetylhexosaminidase activity against pNPβGlcNAc in E. coli cells car-
rying nahA (pNAKS), nahB (pNAP-1) or nahC (pNAP-3). (B and D) Arylesterase and sialate O -acetylesterase activities measured
in E. coli strains carrying estA estS (pNAND240), estS (pNAND241) or pNAND244 (estA) using pNPA and mucin, respectively. (C
and E) Arylesterase and sialate O -acetylesterase activities of EstS expressed in B. uniformis. (F) β -mannosidase activity against
pNPβMan in E. coli cells harboring pNAND170 (bmnA). (G) β -galactosidase activity produced by E. coli cells harboring pNAND300
(bgaA) or pNAND400 (bgaB ) was measured using pNPβGal.
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measured using pNPβGal. The pNAND300 plasmid
produced a high level of β -galactosidase activity,
while no activity was detected from pNAND400. β -
glucuronidase activity against pNPβGlcU was also
absent in the β -glucuronidase-negative E.coli mu-
tant harboring the pNAND400 plasmid (data not
shown). In addition, introduction of a shuttle plas-
mid carrying the bgaB gene into B. uniformis did
not result in an increase of either β -galactosidase
or β -glucuronidase activity when compared to B.
uniformis carrying the control plasmid pVAL-1 (data
not shown).
Although the amnA product showed a weak simi-
larity to α -1,2-mannosidase of Bacillus spp. , α-man-
nosidase activity against pNPαMan was not ob-
served in an E. coli strain carrying amnA (data not
shown). Thus, the functional assignments found by
a BLAST search for putative glycosylhydrolase
genes in the sgu locus were confirmed experimen-
tally, with the exceptions of nahA , amnA , and bgaB .
Transcriptional analysis of the sgu locus
To determine whether the genes in the sgu locus
were co-transcribed, reverse transcription (RT)-
PCR analysis using primer sets encompassing the
neighboring ORFs was performed on total RNA ex-
tracted from a mid-logarithmic phase culture of B.
fragilis YCH46 grown in GAM broth. As shown in
Fig. 5A and 5B, the RT reaction produced no cDNA
from the primer set spanning BF1727-nanH1 , indi-
cating that the transcription of BF1727 does not
extend into nanH1 . All of the other primer sets gen-
erated products of expected sizes, suggesting that
the members of the sgu locus (nanH1 to bgaB ) are
Fig. 5. Transcriptional analysis of the sgu locus. (A and B) Co-transcription with adjacent genes in the sgu locus assayed by RT-
PCR. (A) The locations of the amplified fragments encompassing neighboring ORFs are indicated by black bars. The predicted sizes
of amplification products are shown in the parentheses under the bars. ORFs are represented by open boxes as in Fig. 2. The bent
arrows indicate putative Bacteroides promoters. (B) Agarose gel electrophoresis of the RT-PCR products. Lane numbers correspond
to the amplified regions shown in panel A. M, 100-bp DNA ladder size markers. (C and D) Effects of growth phase and type of car-
bon source on the expression levels of sgu genes. (C) B. fragilis YCH46 was grown in PY medium supplemented with 0.5% glucose
(closed circles) or 0.5% mucin (open circles) as the carbon source. Numbers around the growth curves indicate the points of cell
harvest. (D) Expression levels of sgu genes assessed by RT-PCR analysis. Lane numbers indicate the harvest points shown in panel
C. 16S rRNA was used as an internal control. (E) Effects of various types of sugars on the expression of sgu genes. Total RNA was
isolated from B. fragilis YCH46 cells harvested at mid-logarithmic phase in PY medium supplemented with glucose (lane 1), sialic
acid (lane2), starch (lane 3), colominic acid (lane 4), mucin (lane 5), fetuin (lane 6), asialofetuin (lane 7), or chitin (lane 8) as the car-
bon source. RT-PCR analysis was performed using 25 ng of each RNA sample. 16S rRNA was used as an internal control for RT-PCR.
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organized in an operon, which is transcribed from
the promoter upstream of nanH1 . However, tran-
scriptional analysis by RT-PCR of cultures at various
phases of growth in PY medium supplemented with
glucose or mucin as the carbon source showed com-
plex expression patterns of the sgu genes (Fig. 5C
and 5D). When B. fragilis YCH46 cells were grown
in PY medium supplemented with mucin, the tran-
scriptional levels of all of the sgu genes were ele-
vated in the early- to mid-logarithmic phases, with
a gradual decrease in early stationary phase. In con-
trast, the addition of glucose markedly repressed
the expression of nanH1 , nahA , estA , estS , nanM ,
BF1739, BF1740, and bgaB when the cells were at
mid-logarithmic to stationary phase. The transcrip-
tion of nanH1 was completely repressed in the pres-
ence of glucose at all growth phases tested. bmnA ,
nahB , nahC , amnA , and bgaA were expressed con-
stitutively and were not influenced by culture phase
or carbohydrate source. These results indicated that
the genes in the sgu locus could be divided into
several regulatory units that change their expres-
sion levels depending on carbohydrate availability.
Effects of carbon source on the transcriptional
expression of sgu genes
To further evaluate the effects of carbohydrate
availability on the transcriptional expression of sgu
genes, B. fragilis YCH46 cells were grown to mid-
logarithmic phase in PY medium supplemented with
0.5% monosaccharide (glucose or sialic acid) or 0.5%
polysaccharide (starch, colominic acid, mucin, fe-
tuin, asialofetuin or chitin) as a carbon source (Fig.
5E). Glucose markedly repressed the expression of
nanH1 , nahA , estA , estS , nanM , BF1739, BF1740
and bgaB , but not the expression levels of of bmnA ,
nahB , nahC , amnA and bgaA (lane 1 in Fig. 5E). In
contrast, sialic acid induced the expression of
nanH1 , nahA , estA , and estS (lane 2 in Fig. 5E). As
shown in Fig. 5E, the expression of these sialic
acid-inducible genes was also induced by sialogly-
coconjugates such as colominic acid (lane 4), mucin
(lane 5) and fetuin (lane 6), but not by asialopoly-
saccharides such as asialofetuin and chitin (lanes
7 and 8). In addition, when cells were grown on
starch, very low levels of nanH1 , nahA , estA , estS ,
nanM , BF1739, BF1740, and bgaB expression were
observed (lane 3). Based on these results, the sgu
locus can be divided into three regulatory units : unit
1 (nanH1 , nahA , estA , and estS ), which is induced
by sialic acid or sialated polysaccharides ; unit 2
(nanM , BF1739, BF1740, and bgaB ), which is ex-
pressed constitutively but suppressed by glucose or
its polymer ; and unit 3 (bmnA , nahB , nahC , amnA ,
and bgaA), which is expressed constitutively.
Growth of SGUM172941 in vitro and in vivo
To assess the role of the sgu locus on B. fragilis
growth, we compared the in vitro growth of wild type
and SGUM172941 strains (Fig. 6A). SGUM172941
Fig. 6. Effect of sgu locus deletion on in vitro growth (A) and in vivo colonization (B) on B. fragilis. (A) Comparison of growth
rates between wild type (black) and SGUM172941 mutant (white) strains inoculated into PY broth supplemented with glucose (cir-
cle) or mucin (square) as the sole carbon source. (B) A cocktail containing equal numbers of wild type and SGUM172941 mutant
cells (2.0108 viable cells each) was orally administered to IQI/Jic germ-free mice. One week after challenge, the ileal mucosa, il-
eal contents, caecal contents, colonic mucosa, and colonic contents were collected and diluted with phosphate-buffered saline. Ap-
propriate dilutions were plated on GAM agar plates. Ratios of the strains in each sample were calculated from PCR analysis. Results
are expressed as the meanstandard deviation. Closed and gray bars indicate wild- type and SGUM172941 strains, respectively.
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grew more slowly than wild type when they were
cultured in PY medium supplemented with 0.5% mu-
cin. However, both strains showed similar in vitro
growth rates until late-logarithmic phase in PY me-
dium containing glucose.
A gut colonization assay was performed to deter-
mine whether the sgu locus is essential for B. fragilis
colonization in the intestine (Fig. 6B). A mixture
containing an equivalent number of wild type and
SGUM172941 strains was orally inoculated into
germ-free mice. The wild type/SGUM172941 mu-
tant ratio was assayed at 7 days after post-inocula-
tion. The number of SGUM17294 mutant cells in all
samples (ileal mucosa, ileal contents, caecal con-
tents, colonic mucosa, and colonic contents) was re-
duced to nearly one-fifth the level of wild type cells.
These results indicate that the sgu locus plays
an important role in the colonization process of B.
fragilis in the host intestine by providing the capa-
bility to utilize complex host-derived polysaccha-
rides such as mucin.
DISCUSSION
Sialic acid is a component of glycoproteins, gly-
colipids and various polysaccharides on mammal-
ian cell surfaces. Sialylation is a common and func-
tionally important modification of the glycoconju-
gates of vertebrates and some invertebrate species,
and sialoglycoconjugates are involved in numerous
biological and physiological processes, particularly
intercellular and cell-molecule interactions (14, 27,
28). In the mammalian gut, sialoglycoconjugates are
present on epithelial cell surfaces or in mucins.
They show a great deal of structural complexity and
diversity for evasion from pathogenic microbes, and
the creation of mutually beneficial symbiotic rela-
tionships with nonpathogenic resident microflora
(29). Intestinal residents have evolved a variety of
gene repertoires for polysaccharide degradation
through gene duplication or horizontal gene trans-
fer to adapt to the structural heterogeneity of host-
derived polysaccharides (3, 9, 30). The release of
sialic acids from non-reducing ends by the action
of sialidase is an initial step of sequential degrada-
tion of sialoglycoconjugates since sialic acid resi-
dues prevent the breakdown of sialoglycoconjugates
by the action of other glycosylhydrolases. Another
key enzyme for mucin degradation is sialate O -
acetylesterase. Sialic acids in human rectal mucin
are substituted by acetyl esters to a greater degree
than in any other part of the gut (40% of total
sialic acids). The O -acetyl esters on the hydroxyl
groups at positions C7, C8, and C9 (17, 31-33) in-
hibit the rate of sialic acid cleavage by sialidase.
Thus, the cooperative action of sialidase and sialate
O -acetylesterase plays a crucial role in the degra-
dation of sialoglycoconjugate carbohydrate chains
like mucin (17, 34). In addition, it has been shown
that the relative content of sialic acid and O-ace-
tylated sialic acids in human intestinal mucin in-
creases proportionally from the ileum to the rectum
(32), indicating that sialidase and sialate O-acetyles-
terase play key roles in mucin utilization of micro-
biota in the lower intestine. Most of the sequenced
Bacteroides species possess sialidase and sialate O -
acetylesterase homologues. Presumably, colocaliza-
tion of nanH and estA/S in the sgu locus enables the
cooperative action of both enzymes for efficient
degradation of highly sialylated colonic mucin and
contributes to the dominance of Bacteroides in the
distal gut. Comparative PCR scanning analysis of
the sgu locus revealed that the genetic structure of
the region is conserved among B. fragilis strains
and that the regions corresponding to regulatory
units 1 and 3 are also conserved in other Bacteroides
such as B. vulgatus and B. thetaiotaomicron . Further-
more, growth of the SGUM172941 mutant is inhib-
ited when it is cultured in PY medium supplemented
with mucin. Since SGUM172941 did not show a
complete growth defect in mucin-supplemented
medium, it is possible that mucin degradation can
be attributed to other nanH paralogues (nanH2 ,
nanH3 , or nanH4). These observations indicate that
the sgu locus plays an important role in Bacteroides
nutrient acquisition in sialic acid-rich host environ-
ments like the human distal gut.
Transcriptional analysis of the sgu locus by RT-
PCR using primer pairs that encompassed neigh-
boring genes revealed that the region appeared to
be transcribed polycistronically (Fig. 5). However,
the transcription of this locus seemed to be regu-
lated in a complex manner. The sgu genes can be
classified into three regulatory units on the basis
of transcriptional profiles in response to glucose,
sialic acids, and sialo- (mucin and fetuin) and asialo-
oligosaccharides (starch and asialofetuin). Genes
categorized in the same regulatory unit also showed
similar growth phase-dependent expression pat-
terns. The genes categorized in regulatory unit 1 are
predicted to play a key role in sialoglycoconjugate
degradation since they are rate-limiting genes, such
as nanH1 and estA/S , which are induced by sialic
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acid and sialoglycoconjugates. Genes in regulatory
units 2 and 3 are expressed constitutively, but the
expression of genes in regulatory unit 2 (nanM ,
BF1739, BF1740, and bgaB ) are suppressed by glu-
cose. The low levels of RT-PCR products for regu-
latory unit 2 genes when starch was used as the sole
carbon source resulted from repressed expression
by the increasing glucose concentration following
the degradation of starch by α -glucosidase. Genes
belonging to regulatory units 2 and 3 were not in-
duced specifically by sialoglycoconjugates such as
mucin and fetuin, suggesting that these genes are
expressed constitutively for efficient degradation of
de-sialylated glycoconjugates by the action of siali-
dase and sialate O -acetylesterase. Further analysis
is needed to elucidate the complex regulatory
mechanism(s) of the sgu locus.
The in vivo colonization competition assay dem-
onstrated for the first time that the genes involved
in degradation of sialoglycoconjugates have an es-
sential role in B. fragilis colonization into the gut.
The population level of SGUM172941 decreased to
approximately 14% of the level of wild type cells
one week after a mutant-wild type mixture of cells
was orally administered to IQI/Jic germ-free mice.
In vivo comparative transcriptome analysis of B.
thetaiotaomicron demonstrated that the expression
levels of sgu gene homologues (BT0455-BT0461)
were elevated 2- to 10- fold in the ceca of monoas-
sociated gnotobiotic mice compared to their expres-
sion in minimal medium plus glucose as the sole
fermentable carbon source (12). Furthermore, these
paralogs were expressed at higher levels in mice
fed a simple-sugar diet than in mice fed a dietary
polysaccharide-rich diet, indicating that the expres-
sion of this cluster is up-regulated to utilize host
mucus glycans when polysaccharide availability from
the diet is reduced (12). These findings indicate
that the sgu locus is associated with the utilization
of host-derived glycans such as mucin, and helps
B. fragilis make close contact with the mucosal sur-
face.
Genomic analysis of Bacteroides species revealed
that they have evolved an exceptional ability to util-
ize polysaccharides through the extensive amplifi-
cation of genes involved in polysaccharide binding,
degradation and transport (1-3). Gene duplication
is more extensive in B. thetaiotaomicron , which is
likely correlated with its cell density in the colon,
with a cell number that is 10- to 100-fold higher
than that of B. fragilis . However, B. fragilis pos-
sesses a larger number of sialidase paralogues (four
in B. fragilis vs. two in B. thetaiotaomicron). Consid-
ering the findings reported by Namavar et al. (35),
in which B. fragilis is the predominant member of
the B. fragilis group found on the gut mucosal sur-
face but is in the minority in feces, it seems that
host-derived sialoglycoconjugates, especially mucin,
are major nutrient source for this anaerobe as well
as host diet. Expansion of the sialidase gene would
be beneficial not only for nutrient acquisition but
also for infectious potential of B. fragilis . Therefore,
exploration of the transcriptional regulation on sgu
locus is needed to advance our understanding of the
biology of B. fragilis .
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